P. Fumoleau

Current status of Taxotere® (docetaxel) as a new treatment in breast cancer

M. Glabbeke, P. Fumoleau, V. Diéras, 2004, Breast Cancer Research and Treatment.

Premenopausal Patients with Node-Positive Resectable Breast Cancer

S. Schraub, M. Namer, P. Fumoleau, 2012, Drugs.

348 A phase II trial of docetaxel in patients (PTS) with anthracycline resistant (AR) metastatic breast cancer (MBC)

M. Piccart, A. Nichol, J. Bonneterre, 1995 .

Appropriate cytotoxic drugs usages in solid tumors: Impact of appropriate use referentials

X. Pivot, P. Arveux, S. Limat, 2012 .